• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-Q filed by Bright Green Corporation

    8/15/24 5:00:32 PM ET
    $BGXX
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $BGXX alert in real time by email
    NT 10-Q 1 formnt10-q.htm

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 12b-25

     

    NOTIFICATION OF LATE FILING

     

    SEC FILE NUMBER: 001-41395

     

    CUSIP NUMBER: 10920G100

     

    (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-CEN
      ☐ Form N-CSR          

     

      For Period Ended June 30, 2024
       
      ☐ Transition Report on Form 10-K
      ☐ Transition Report on Form 20-F
      ☐ Transition Report on Form 11-K
      ☐ Transition Report on Form 10-Q
       
      For the Transition Period Ended ______________________

     

    Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

     

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

     

    PART I - REGISTRANT INFORMATION

     

    Bright Green Corporation

    Full Name of Registrant

     

    N/A

    Former Name if Applicable

     

    1033 George Hanosh Boulevard

    Address of Principal Executive Office (Street and Number)

     

    Grants, NM 87020

    City, State and Zip Code

     

     

     

     
     

     

    PART II - RULES 12b-25(b) AND (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate).

     

    ☒ (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
    (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
    (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

     

    PART III - NARRATIVE

     

    State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

     

    Bright Green Corporation (the “Company”) is unable to file, without unreasonable effort or expense, its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 (the “10-Q”)‎ within the prescribed time period because additional time is required to finalize its financial statements and related disclosures required to be included in the 10-Q. The Company expects to file the 10-Q within five calendar days following the prescribed due date.

     

    PART IV - OTHER INFORMATION

     

    (1) Name and telephone number of person to contact in regard to this notification

     

    Saleem Elmasri   (833)   658-1799
    (Name)   (Area Code)   (Telephone Number)

     

    (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). ☒ Yes ☐ No
       
    (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☐ Yes ☒ No

     

    If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

     
     

     

    Bright Green Corporation

    (Name of Registrant as Specified in Charter)

     

    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date August 15, 2024   By: /s/ Saleem Elmasri
          Name:  Saleem Elmasri
          Title: Chief Financial Officer

     

     

     

    Get the next $BGXX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BGXX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BGXX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Elmasri Saleem sold $4,951 worth of shares (25,942 units at $0.19), decreasing direct ownership by 2% to 1,103,476 units (SEC Form 4)

    4 - Bright Green Corp (0001886799) (Issuer)

    9/11/24 4:05:11 PM ET
    $BGXX
    Medicinal Chemicals and Botanical Products
    Health Care

    Chief Financial Officer Elmasri Saleem sold $14,313 worth of shares (71,809 units at $0.20), decreasing direct ownership by 6% to 1,129,418 units (SEC Form 4)

    4 - Bright Green Corp (0001886799) (Issuer)

    9/10/24 4:05:08 PM ET
    $BGXX
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: Chief Executive Officer Singh Gurvinder was granted 5,500,000 shares (SEC Form 4)

    4/A - Bright Green Corp (0001886799) (Issuer)

    9/9/24 4:05:32 PM ET
    $BGXX
    Medicinal Chemicals and Botanical Products
    Health Care

    $BGXX
    SEC Filings

    View All

    SEC Form 25-NSE filed by Bright Green Corporation

    25-NSE - Bright Green Corp (0001886799) (Subject)

    3/21/25 11:19:49 AM ET
    $BGXX
    Medicinal Chemicals and Botanical Products
    Health Care

    Bright Green Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Bright Green Corp (0001886799) (Filer)

    3/21/25 9:15:14 AM ET
    $BGXX
    Medicinal Chemicals and Botanical Products
    Health Care

    Bright Green Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Financial Statements and Exhibits

    8-K - Bright Green Corp (0001886799) (Filer)

    2/27/25 4:05:24 PM ET
    $BGXX
    Medicinal Chemicals and Botanical Products
    Health Care

    $BGXX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lynn Stockwell and Bright Green Corporation File $3 Billion Lawsuit Against Rodey Law Firm and Attorneys' Liability Assurance Society (ALAS) for Legal Malpractice and Bad Faith

    Court Found No Wrongdoing by Lynn Stockwell; Judgment Imposed Joint and Several Liability Due to Counsel's Failure Cibola County, New Mexico, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bright Green Corporation (OTC:BGXXQ) and its Chief Executive Officer, Lynn Stockwell, today announced the filing of a landmark lawsuit seeking damages in excess of $3 billion against Rodey Law Firm and Attorneys' Liability Assurance Society (ALAS). The complaint, filed in the Thirteenth Judicial District Court of New Mexico, alleges legal malpractice, breach of contract, and bad faith breach of fiduciary duty. The underlying litigation resulted in findings of no wrongdoing by Lynn Stockwell. Despite this, the court

    1/8/26 9:00:00 AM ET
    $BGXX
    Medicinal Chemicals and Botanical Products
    Health Care

    PharmAGRI Capital Partners Targets $10 Billion Federal Procurement Opportunity for Onshored Plant-Based Prescription Drugs Bright Green Corporation "BGXXQ" Q and A

    Fort Lauderdale, FL, Sept. 16, 2025 (GLOBE NEWSWIRE) -- PharmAGRI Capital Partners today announced its strategic focus on capturing a $10 billion total addressable market (TAM) in federal procurement of plant-based prescription drugs currently sourced from foreign manufacturers. This segment, while modest in size compared to the broader pharmaceutical industry, represents a critical opportunity to restore control, compliance, and domestic production with a fair transparent pricing model. CEO Statement: "The $10B TAM is not about volume—it's about control. Federal agencies already procure these drugs, often from foreign sources. Our goal is to ensure they contract with a sovereign platfor

    9/16/25 3:14:00 PM ET
    $BGXX
    Medicinal Chemicals and Botanical Products
    Health Care

    Bright Green Corporation Merges with PharmAGRI Capital Partners; Lynn Stockwell Appointed CEO and Chairwoman

    Tesla Robotics to Power Sovereign "Seed to Syringe" Pharmaceutical Infrastructure Fort Lauderdale, FL, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Bright Green Corporation (OTC:BGXX) has announced its merger with PharmAGRI Capital Partners, a federally aligned pharmaceutical infrastructure platform architected to restore U.S. drug manufacturing sovereignty. The transaction consolidates BGXX's DEA registrations, Board of Pharmacy licensure, audited financials, and Nasdaq history into PharmAGRI under a court-supervised restructuring plan filed in the District of New Mexico. Effective immediately, Lynn Stockwell has been appointed Chief Executive Officer and Chairwoman of PharmAGRI. Ms. Stockwell wi

    9/15/25 8:02:14 PM ET
    $BGXX
    Medicinal Chemicals and Botanical Products
    Health Care

    $BGXX
    Leadership Updates

    Live Leadership Updates

    View All

    (Updated) U.S. Legal Cannabis Pioneer Bright Green Corporation Appoints Industry Veteran Groovy Singh as New Chief Executive Officer

    Singh's appointment comes in support of the Company's next evolution, which will be focused on investing in top talent, commencement of commercial operations, and investing in clinical research and development of plant based therapies, and expanding into cultivation and manufacturing of other scheduled substances. GRANTS, N.M., Jan. 14, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ:BGXX) ("Bright Green" or "the Company"), announced today their appointment of Groovy Singh, a renowned leader and strategist in the cannabis and wellness industries, as Chief Executive Officer. Singh will replace current CEO Seamus McAuley, who is stepping back from the position to address recently

    1/14/24 10:00:00 AM ET
    $BGXX
    Medicinal Chemicals and Botanical Products
    Health Care

    U.S. Legal Cannabis Pioneer Bright Green Corporation Appoints Industry Veteran Groovy Singh as New Chief Executive Officer

    Singh's appointment comes in support of the Company's next evolution, which will be focused on investing in top talent, commencement of commercial operations, and investing in clinical research and development of plant based therapies, and expanding into cultivation and manufacturing of other scheduled substances. GRANTS, N.M., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ:BGXX) ("Bright Green" or "the Company"), announced today their appointment of Groovy Singh, a renowned leader and strategist in the cannabis and wellness industries, as Chief Executive Officer. Singh will replace current CEO Seamus McAuley, who is stepping back from the position to address recently

    10/3/23 11:11:00 AM ET
    $BGXX
    Medicinal Chemicals and Botanical Products
    Health Care

    Bright Green Announces First Quarter 2023 Financial Update and Milestone Progress

    Bright Green has achieved several key milestones throughout the Quarter significantly advancing progress against its strategic plan, including a historic DEA Federal Registration and License Approval. Commencement of its fundamental capital raise of $500+ million utilizing the U.S. Citizen & Immigration Services EB-5 program, alongside the recently announced full acquisition of Alterola Biotech, showcases the Company's significant progress against its strategic plan. Company has raised short-term working Capital of $5.26m to commence its operations as it looks to capitalize on its historic DEA Registration in Q2 2023 and beyond. GRANTS, N.M., May 24, 2023 (GLOBE NEWSWIRE) -- Brig

    5/24/23 8:00:00 AM ET
    $BGXX
    Medicinal Chemicals and Botanical Products
    Health Care

    $BGXX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Bright Green Corporation (Amendment)

    SC 13D/A - Bright Green Corp (0001886799) (Subject)

    9/6/23 5:19:19 PM ET
    $BGXX
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13D filed by Bright Green Corporation

    SC 13D - Bright Green Corp (0001886799) (Subject)

    6/15/23 4:30:21 PM ET
    $BGXX
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by Bright Green Corporation (Amendment)

    SC 13G/A - Bright Green Corp (0001886799) (Subject)

    6/12/23 5:28:12 PM ET
    $BGXX
    Medicinal Chemicals and Botanical Products
    Health Care